The authors gratefully acknowledge the following individuals for their contributions to this project and deeply appreciate their considerable support, commitment, and contributions: Aysegul Gozu, M.D., M.P.H., and Kim Wittenberg, M.A., our AHRQ Task Order Officers (TOOs); RTI International–University of North Carolina at Chapel Hill EPC staff: Rania Ali, M.P.H.; Sharon Barrell, M.A.; Josh Green, B.A.; Loraine Monroe; Christiane Voisin, M.S.L.S.; Rachel Weber, Ph.D.; Carol Woodell, B.S.P.H. We also thank representatives from the American Academy of Child and Adolescent Psychiatry (Heather Walter, Ronald Szabat, and Karen Ferguson). Finally, we thank Tiffany R. Farchione, M.D., Deputy Director (Acting), Division of Psychiatry Products, Center for Drug Evaluation and Research, Office of New Drugs, U.S. Food and Drug Administration.